Company Filing History:
Years Active: 2012-2013
Title: Nadine Dejneka: Innovator in Vascular Research
Introduction
Nadine Dejneka is a prominent inventor based in Wynnewood, PA (US). She has made significant contributions to the field of vascular research, particularly in the development of innovative therapies targeting vascular endothelial growth factor (VEGF). With a total of 2 patents, her work has the potential to impact the treatment of various diseases associated with angiogenesis.
Latest Patents
Nadine's latest patents include compositions and methods for selective inhibition of VEGF. These patents disclose siRNA compositions and methods that are useful for inhibiting the expression of VEGF isoforms. The compositions are designed to selectively target angiogenic VEGF isoforms while sparing anti-angiogenic isoforms. This innovation is particularly relevant for treating diseases such as diabetic retinopathy, age-related macular degeneration, and various types of cancer. Another patent focuses on the inhibition of VEGF, emphasizing the therapeutic potential of small interfering RNAs in managing conditions driven by the overexpression of VEGF.
Career Highlights
Throughout her career, Nadine has worked with notable companies, including Opko Pharmaceuticals and Opko Ophthalmics. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Nadine has had the opportunity to work alongside esteemed colleagues such as Phillip Frost and Ottrina S Bond. These collaborations have further enriched her research and innovation efforts.
Conclusion
Nadine Dejneka's contributions to vascular research and her innovative patents position her as a key figure in the fight against diseases related to angiogenesis. Her work continues to inspire advancements in medical therapies and offers hope for patients affected by these conditions.